Little is known about lipid transport and metabolism in the brain. As a further step toward understanding the origin and function of CNS lipoproteins, we have characterized by size and density fractionation lipoprotein particles from human CSF and primary cultures of rat astrocytes. The fractions were analyzed for esterified and free cholesterol, triglyceride, phospholipid, albumin, and apolipoproteins (apo) E, Al, All, and J. As determined by lipid and apolipoprotein profiles, gel electrophoresis, and electron microscopy, nascent astrocyte particles contain little core lipid, are primarily discoidal in shape, and contain apoE and apoJ. In contrast, CSF lipoproteins are the size and density of plasma high-density lipoprotein, contain the core lipid, esterified cholesterol, and are spherical. CSF lipoproteins were heterogeneous in apolipoprotein content with apoE, the most abundant apolipoprotein, localized to the largest particles, apoAl and apoAll localized to progressively smaller particles, and apoJ distributed relatively evenly across particle size. There was substantial loss of protein from both CSF and astrocyte particles after density centrifugation compared with gel-filtration chromatography. The differences between lipoproteins secreted by astrocytes and present in CSF suggest that in addition to delivery of their constituents to cells, lipoprotein particles secreted within the brain by astrocytes may have the potential to participate in cholesterol clearance, developing a core of esterified cholesterol before reaching the CSF. Study of the functional properties of both astrocyte-secreted and CSF lipoproteins isolated by techniques that preserve native particle structure may also provide insight into the function of apoE in the pathophysiology of specific neurological diseases such as Alzheimer's disease. Key Words: Apolipoprotein E-Apolipoprotein J -Apolipoprotein Al -Alzheimer's disease-Cholesterol. J. Neurochem. 70, 2070Neurochem. 70, -2081Neurochem. 70, (1998.
The intercellular transport of lipids through the aqueous circulatory system requires the packaging of these hydrophobic molecules into water-soluble carriers known as lipoproteins (high-density lipoprotein HDL; low-density lipoprotein LDL; and very-low-density lipoprotein, VLDL). Lipoproteins are macromolecular complexes composed of a phospholipid (PL) and free cholesterol (FC) shell surrounding a triglyceride (TG) and cholesteryl ester (CE) core (see Fig.  6A ). Lipoproteins also contain apolipoproteins (apo), proteins that stabilize the surface of lipoproteins as they have both hydrophobic and hydrophilic domains. Apolipoproteins can also serve as cofactors for enzymatic reactions (Fielding et al., 1972) and ligands for cell surface receptors (Brown and Goldstein, 1986) . In addition, alterations in apolipoproteins are associated with pathological conditions (Mahley, 1988) . Whereas the regulation of lipoprotein metabolism and its effects on systemic lipid regulation have been studied extensively, much less is known about lipid transport and metabolism in the CNS. Because the percentage of lipid within the CNS is higher than any organ (Davison, 1965) and because of the unique function and structure of nerve cells, it is likely that a better understanding of lipoprotein metabolism in the CNS will give insight into mechanisms of both neural development and plasticity. This may be particularly relevant with regard to the potential involvement of apolipoprotein E (apoE) in CNS lipoprotein metabolism. This is highlighted by the fact that a single amino acid difference in apoE is a major risk factor for both familial and sporadic Alzheimer's disease (AD) (Strittmat-ter et al., 1993a; Strittmatter and Roses, 1996) , as well as a predictor for survival after head injury and intracerebral hemorrhage (Alberts et al., 1995; Nicoll et al., 1995) , suggesting that regulation of lipoprotein metabolism in the brain may be important during AD and CNS injury. In humans, apoE has three major isoforms, E2 (Cysti 2 and Cys'58), E3 (CysH2 and Arg'58), and E4 (Arg'12 and Arg'58), which are products of alleles at a single gene locus (Mahley, 1988) . The apoE4 isoform is correlated with CNS pathology.
The CNS is isolated from other body compartments by the blood-brain barrier. The constituents of the CSF provided the first evidence that lipoprotein metabolism within the CNS was distinct from that in the periphery (Roheim et al., 1979) . CSF is produced by the choroid plexus and also contains nonresorbed products derived from the interstitial space of the brain and, to a smaller degree, plasma. Studies have shown that several apolipoproteins are present in the CSF, with the two most abundant being apoE and apoAl (Roheim et al., 1979; Pitas et al., l987b) . These proteins appear to reside in distinct lipoprotein particles that are HDLlike in density as determined by gradient centrifugation (Pitas et al., 1987b) . It is noteworthy that apoE found in the CSF is produced within the CNS. In patients who have undergone liver transplantation, the plasma apoE phenotype changes to that of the donor whereas apoE protein in the CSF remains the phenotype of the recipient (Linton et al., 1991) . A further understanding of how apoE produced locally within the brain influences cholesterol/lipid metabolism under physiological and pathophysiological conditions may give novel insights into why apoE4 is a risk factor for AD and poor outcome after CNS injury.
ApoE in the CNS appears to be produced predominantly by astrocytes (Boyles et al., 1985; Pitas et al., 1987a) and microglia (Nakai et al., 1996; Stone et al., 1997) , and apoE receptors are present on glia and neurons (Pitas et al., 1987a; Moestrup et al., 1992; Wolf et al., 1992; Poirier et al., 1993; Rebeck et al., 1993; Bu et a!., 1994) . In vitro, astrocytes secrete apoE-containing lipoproteins (Pitas et al., 1987a) , although the nature of this lipoprotein particle has not been determined. In vivo, expression of apoE by astrocytes in the CNS is up-regulated severalfold after partial hippocampal deafferentation (entorhinal cortex lesion) and in AD (Diedrich et al., 1991; Poirier et al., 1991; Poirier, 1994) . These studies have led to models in which apoE is hypothesized to play a role in cholesterol and lipid uptake and redistribution after injury to the CNS (Boyles et a!., 1989; Poirier, 1994) .
It is clear that apoE in the CNS is produced by glia and is present in CSF lipoprotein particles. What remains to be defined are the characteristics of lipoprotein particles secreted by astrocytes as well as a detailed analysis of lipoprotein particles present in CSF. Such information may provide new insights into lipoprotein metabolism in the brain as well as into how alterations in apoE phenotype may play a role in the pathogenesis of AD and recovery from brain injury. The technique of density centrifugation allows for isolation of lipoproteins from body fluids. However, the apoprotein composition of plasma-derived lipoproteins, particularly the distribution of apoE, has been shown to be significantly altered after this procedure (Fainaru et al., 1975; Kunitake and Kane, 1982; Castro and Fielding, 1984) . In this study, we used both gradient centrifugation and gel-filtration chromatography to isolate, characterize, and compare lipoproteins from fresh human CSF and serum-free conditioned media from primary cultures of rat astrocytes. Lipoproteins isolated by these methods from both CSF and astrocytes were comparable in size and density with large, buoyant HDL particles. Although CSF contained several apolipoproteins, astrocyte-secreted particles contained only apoE and apoJ. In addition to differences in apoprotein composition, CSF particles contained CE characteristic of spherical HDL-like particles, whereas astrocyte lipoproteins were deficient in CE, suggesting discoidal particles, observations that were confirmed by electron microscopy. These studies suggest that in addition to delivery of their constituents to cells via apoE receptors, lipoprotein particles secreted in brain parenchyma by astrocytes may have the potential to accumulate cholesterol and develop a CE core before reaching the CSF. Because lipoprotein composition is known to affect activity, analysis of astrocyte-produced lipoproteins will be important in understanding the functional role of apoE-containing lipoproteins in the normal brain, in AD, and after CNS injury.
MATERIALS AND METHODS

Human CSF
Human CSF was obtained from adult patients undergoing workup for a possible neurological disorder. All specimens consisted of fluid that was not used for other diagnostic purposes. Samples of 3-5 ml of CSF per patient were pooled into 50-ml aliquots, stored at 4°C, and analyzed within 2 months. CSF was only used if the red blood cell count was <20 cells/mm3 and the total protein was <80 mg/dl. No apoB was detected in the CSF samples, indicating a lack of plasma contamination.
Preparation of astrocyte-conditioned medium
Astrocyte cultures were prepared from neonatal (1-2-day-old) Sprague-Dawley rats as described (Levinson and McCarthy, 1991) . Cerebral cortex was dissected out, trypsinized, and cells cultured in 100-mm tissue-culture plates in a-minimum essential medium (a-MEM; GIBCO, Grand Island, NY, U.S.A.) containing 10% fetal bovine serum (Hyclone Laboratories, Logan, UT, U.S.A.) and antibiotics (100 U/mI penicillin and 100~g/ml streptomycin). Cultures were maintained at 37°Cin a humidified 5% C0 2-containing atmosphere for 11 days. Cells were then trypsinized and replated into 100-mm plates at a density of -~6 x iocells per plate and grown for 10 days (Hu et al., 1996) . These cultures consist of >95% astrocytes with a small percentage of the cells being other kinds of glia (microglia and oligodendrocytes) (Hu et al., 1996) . Medium from confluent cultures was removed, cells were washed twice with phosphate-buf-fered saline, and then cultures were incubated in 5 ml of a-MEM containing N2 supplements (GIBCO) for an additional 72 h. Conditioned medium was removed, clarified by centrifugation at '-800 g for 5 mm, and stored at 4°Cuntil analysis.
Fractionation
Both astrocyte-conditioned media and pooled CSF samples were concentrated (Centriprep-10, Amicon) '-50-fold before fractionation.
Gel-filtration chromatography. One milliliter of concentrated CSF or astrocyte-conditioned media was fractionated by gel-filtration chromatography, using fast protein liquid chromatography with tandem Superose 6 columns (Pharmacia), in 0.02 M sodium phosphate, 0.05 M NaC1, pH 7.4, 0.03% EDTA, and 0.02% sodium azide. Sixty fractions of 400 p1 each were collected and analyzed. Flow rate of the column was at 4 ml/min at 20°C.
Ultracentrifugalfiotation. Total lipoprotein: Total lipoproteins were isolated by ultracentrifugal flotation at a density <1.25 g/ml, using standard procedures reviewed by Schumaker and Puppione (1986) . Density gradients: CSF or astrocyte-conditioned media samples were separated on 3-20% sodium bromide single-spin gradients (Cabana et al., 1989 ) by centrifugation at 38,000 rpm in an SW41 Ti rotor for 66 h at 15°C.Thirty fractions of 400~il each were collected and dialyzed against Tris-buffered saline before analysis.
Western analysis
Fractions were dot blotted on Immobilon-P membrane (Millipore), probed for immunoreactivity (antibodies listed below), visualized by enhanced chemiluminescence (ECL, Amersham), and quantitated by densitometry (Molecular Dynamics). For CSF fractions (see Fig. 3A and B), the areas of the apoprotein curves were adjusted to reflect the relative apoprotein concentration in total CSF, where apoE -2.9-5.9~.tg/ml (Pitas et al., 1987b; Caisson et al., 1991; Blennow et al., 1994; Lehtimaki et al., 1995) , apoAl -4.5 ptg/ml (Roheim et al., 1979; Rifai et al., 1986) , apoJ -2.4 g/ml (Choi-Miura et al., 1992) , and apoAll -0.5 ,ug/ml (W. Rebeck, personal communication) . For astrocyte media fractions (see Fig. 3C and D), the areas of apoE and apoi curves were assigned comparable values. The height of the albumin peak was set comparable with the highest apolipoprotein peak for both CSF and astrocyte media (see Fig. 3 ). For sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), samples containing 2x Laemmli buffer [4% SDS, ±10%3-mercaptoethano1(/3ME), as specified in the legend to Fig. 4 ] were boiled 5 mm and electrophoresed on 10-20% SDS-tricine gels. Gels were either stained with Coomassie Blue, or transferred to Immobilon-P membranes and probed as described above.
Human apolipoproteins B, A!, and All and rat apoE and A! were detected with antisera prepared in rabbits from apolipoproteins purified from human plasma. Human apoJ monoclonal antibody 1D11 was generously provided by Dr. Judy Harmony (University of Cincinnati) and rat apoJ antisera from sheep was purchased from Quidel (San Diego).
Human and bovine albumin were detected with rabbit antisera (ICN Biomedicals).
Electron microscopy
Particles isolated by gel-filtration chromatography were examined by using the Philips CM1O electron microscope at the Cummings Laboratory of the University of Chicago.
Samples were stained with 2% sodium phosphotungstate based on established procedures (Forte and Nordhausen, 1986) . The diameters of all intact particles from a quadrant of enlarged prints of photomicrographs were measured by using a micrometer lens until 100 were assessed. Diameter of the particles is expressed as the mean (±S EM).
Lipid analysis
Total cholesterol (TC), TG, FC, CE, and PL were measured enzymatically, using commercially available kits (Boehringer Mannheim for TC, TO, and CE; Wako, Richmond, VA, U.S.A. for FC and FL). Protein was measured using bicinchoninic acid solution (Sigma) with samples and standards solubilized in 2% SDS.
RESULTS
Density gradient centrifugation and gel-filtration chromatography with tandem Superose 6 columns are routinely used to analyze the density and size distribution of plasma lipoproteins. Both techniques are able to separate plasma VLDL, LDL, HDL, and free protein ( Fig. 1 ). These methods were used to compare CSF lipoproteins (CSF-LPs) and lipoproteins from serumfree conditioned medium from primary rat astrocytes (A-LPs). Lipid analysis (PL, TG, TC, FC, and CE) revealed both similarities and differences between CSF-LPs and A-LPs. The ratio of TC to PL was very similar between CSF-LPs and A-LPs, as was the lack of measurable TG ( Fig. 2A and C) . However, most of the TC in the A-LPs was free (82%), with little esterified (18%). This differs from the CSF-LPs in which a majority of the TC was esterified (64%). For the sake of comparison, we describe A-LPs and CSFLPs relative to human plasma HDL species as a reference for size and density. We recognize that variability in apolipoprotein sequence and content may contribute to lipoprotein differences between species. By density centrifugation, although both particle types had a density in the HDL range, CSF-LPs were similar in density to HDL-3 (lipid peak -fraction 22) and A-LPs were closest in density to more buoyant HDL-2 particles (lipid peak '-fraction 19) ( Fig. 2B and D) . As apparent by using gel-filtration chromatography, A-LPs were closest in size to HDL-l (lipid peak '--fraction 36), slightly larger than the CSF-LPs that were similar in size to HDL-2 (lipid peak -fraction 39) ( Fig. 2A  and C) . Although the peak size and density of particles from both sources were similar to those of plasma HDL, both CSF-LPs and A-LPs was a heterogeneous mix that included particles of the size and density of HDL-1 and very-high-density lipoprotein (VHDL). Particles larger and more buoyant than HDL-2 are referred to as HDL-1, apoE-containing particles initially characterized in the plasma of hypercholesterolemic dogs and generally absent from human plasma (Mahley and Weisgraber, 1974) . HDL-l is used rather than LDL to distinguish these particles from apoB-contaming LDL, as apoB is not present in either CSF or astrocyte media. Indeed, the presence of apoB in CSF FIG. 1. Lipoprotein distribution in normal human plasma fractionated by size (A) and density (B). A: Gel-filtration chromatography profile of human plasma fractionated by using tandem Superose 6 columns. B: Single-spin equilibrium ultracentrifugation profile of human plasma fractionated by using 3-20% sodium bromide gradients.
samples is routinely used as a clinical measure of plasma contamination.
Previous studies using immunoaffinity chromatography have suggested that apoE and apoAl reside in distinct particles within the CSF (Pitas et al., 1987b) . By gel filtration, differences between the apoE-and apoAl-containing particles in CSF could be distinguished on the basis of size, with apoE generally in larger particles than those that contained apoAl (Fig.  3A) . The peaks of the apoE-, apoAl-, and apoAllcontaining particles were progressively smaller, comparable in size with plasma HDL-1, HDL-2, and HDL-3, respectively. In contrast, apoJ was distributed fairly evenly across all size ranges. As with the lipid profile, a portion of the particles containing apoE and apoJ were the size of HDL-1 and larger, whereas apoAl, apoAll, and apoJ also localized to VHDL. Density centrifugation of CSF also suggested that apoE and apoAl were in particles comparable with plasma HDL, although it was difficult to resolve any clear differences between the distribution of apoE and apoAl with this technique (Fig. 3B) . Furthermore, most apoJ and a significant amount of all the apolipoproteins were detected in fractions with free protein. To further explore the difference in lipoprotein-isolation techniques, we compared quantitatively the composition of total lipoproteins isolated from CSF and astrocyte-conditioned medium by density centrifugation versus gel-filtration chromatography. Lipid analysis revealed that although there was no major difference in TC or PL between the lipoproteins isolated by the two methods, there was a striking loss of protein from the CSF particles after density centrifugation (Table 1 ). In particles separated by gel chromatography, the relative ratio of protein to lipid (TC or PL) in CSF-LPs is twofold higher than A-LPs, suggesting that CSF particles are protein rich. The ratio of protein to TC in CSF-LPs decreased 89% after centnfugation. Most of this protein loss is due to the loss of apolipoproteins. Although gel-filtration chromatography demonstrates that apoE, apoA!, apoAll, and apoJ elute primarily in lipid-containing fractions (Fig. 3A) , there is clearly a loss of apolipoproteins from CSF-LPs during density centrifugation (Fig. 3B) . A similar phenomenon has been described with plasma lipoproteins (Castro and Fielding, 1984) .
Analysis of A-LPs revealed that the major apolipoproteins were apoE and apoJ, which, by gel-filtration chromatography, were in fractions indicating a size similar to that suggested by lipid analysis (predominantly large HDLs) (Fig. 3C) . ApoAl was not detected. Density centrifugation revealed that apoE localized to particles similar in density to HDL-2 and apoJ localized to denser particles. As with CSF, a significant amount of both proteins also appeared in free-protein fractions, suggesting stripping of some apoprotein from particles during centrifugation (Fig. 3D) . It is noteworthy that although density centrifugation of CSF removed most apoJ from lipid-containing fractions, a larger proportion of apoJ remained associated with lipid in A-LPs, suggesting that the apolipoprotein has a greater affinity for discoidal particles. Although not as much protein was lost from total A-LPs with density centrifugation compared with CSF particles, there was an -30% decrease in the ratio of protein to TC after density centrifugation compared with gel-filtration chromatography (Table 1 ). In addition, the TC/PL ratio for total A-LPs isolated by either gel chromatography or centrifugation was about twice that of total CSF-LPs (Table 1) . This is in contrast to the fractionation profile for the two types of particles, where the
FIG.
2. Lipid distribution in human CSF (A and B) and serum-free conditioned media from primary rat astrocytes (C and D) fractionated by size (A and C) and density (B and D). Fifty milliliters of either CSF (A and B) or astrocyte-conditioned media (C and D) were concentrated to 1 ml and then fractionated by gel-filtration chromatography, using tandem Superose 6 columns (A and C), or by single-spin equilibrium ultracentrifugation, using 3-20% sodium bromide gradients (B and 0). The resulting fractions were analyzed for lipid, which is expressed as micrograms per fraction.
ratios appear comparable and somewhat lower ( Fig.   2A and C). This apparent difference was attributed to the isolation techniques, and the characteristics of total versus fractionated particles.
To further examine the protein composition of CSFLPs and A-LPs, selected gel chromatography fractions were analyzed by SDS-PAGE. Coomassie staining of samples reduced with /3ME confirmed that apoE and apoAl are the primary protein components in CSF fractions containing lipid, whereas apoE is the major protein in astrocyte media fractions containing lipid ( Fig.  4A and B) . These stained gels also show that CSF contains more total and lipid-associated protein than astrocyte media, although the A-LPs actually contain more lipid than the CSF-LPs ( Fig. 2A vs. C) . In general, western analysis of nonreduced samples confirmed the localization of apoproteins to the fractions shown in Fig. 3 . Because the CSF was pooled and contained apoE3 (Cys' 12), apoE was present as a 35-kDa monomer, and as homo-and heterodimers with apoAll, the only other apoprotein with a cysteine residue ( Fig. 4C and H) . Rat apoE has no cysteine residues and so migrated as a single 35-kDa species. ApoJ, also known as SP-40,40, migrated as an 80-kDa dimer ( Fig.   4E and F) . ApoAl is present as a 28-kDa monomer and as noncovalently linked multimers (Fig. 4G) .
Lipid analysis (Fig. 2) suggested that CSF-LPs were spherical with a CE core, whereas A-LPs lacked core lipids and were probably discoidal (Fig. 2) . To confirm the conformation of the particles isolated by gel filtration, both astrocyte and CSF particles were examined by electron microscopy. Analysis of CSF-LP samples containing primarily apoAl (fractions 43/44) or apoE (fractions 37/38) revealed that the lipoprotein particles were spherical ( Fig. 5A and B) . The smaller apoAl-containing particles had a mean diameter of 11.4 nm and the larger apoE-containing particles had a mean diameterof 12.7 nm (Table 2 ). This is comparable with the size and appearance of CSF particles previously observed after density centrifugation in .J. Neurochem., Vol. 70, No. 5, 1998 FIG. 3. Protein distribution in human CSF (A and B) and serum-free conditioned media from primary rat astrocytes (C and 0) fractionated by size (A and C) and density (B and D). Samples were fractionated as described in the legend to Fig. 2 . The distribution of apolipoproteins and albumin in the resulting fractions is expressed in arbitrary densitometric units based on western analysis with the appropriate antibody. In A and B, the areas of the apolipoprotein curves have been adjusted to correspond tothe known concentration of the apolipoproteins in total CSF, and in C and 0, the areas are set equivalently (see Materials and Methods). Phospholipid distribution from Fig. 2 is included to identify the location of the lipid peak.
other studies (Pitas et al., 1987b) . In contrast to the CSF, lipoprotein particles from astrocyte-conditioned media were discoidal in shape, as predicted by their lack of core lipids, and were often seen in stacks (Fig.   SC) . The mean diameter of these discs was larger than particles from the CSF (15.4 nm). Thus, both the size and the conformation as well as the lipid and apolipoprotein composition suggest pronounced differences between lipoproteins secreted by astrocytes and those found in the CSF (see Fig. 6B and C).
DISCUSSION
Lipoproteins are present in CSF, are secreted by glial cells, and have receptors on both glia and neurons, suggesting they are important for normal lipid metabolism in the CNS. Because the size and the density, as well as the apolipoprotein and the lipid composition, of lipoproteins affect their function, we analyzed both human CSF and rat astrocyte-secreted lipoproteins using both gel-filtration chromatography and density centrifugation. We have shown that nascent A-LPs contain little core lipid, are primarily discoidal in shape, and contain apoE and apoJ as the predominant protein components. In contrast, CSF-LPs contain the core lipid CE and are spherical particles the size and density of plasma HDL. In addition, CSF-LPs contain apoE, apoAl, apoAll, and apoJ, and there is heterogeneity within the CSF-LPs with respect to the distribution of these apolipoproteins. Because CSF constituents are derived in part from interstitial fluid from within the brain, it is possible that nascent A-LPs are converted from discs to spherical particles by acquiring CE within the parenchyma of the CNS before reaching the CSF. A-LPs may have important roles in the redistribution of lipid in the CNS.
Small discoidal lipoproteins from the plasma, including particles containing apoE (Forte and Nord- Fifty milliliters of fresh CSF or astrocyte-conditioned media (prepared as described in Materials and Methods) was concentrated to 2 ml. Total lipoproteins from 1 ml were isolated by gel-filtration chromatography and the resulting fractions 1 -46 were pooled and concentrated. Total lipoproteins from the remaining 1 ml were isolated by ultracentrifugal flotation (density <1.25 g/ml). Samples were concentrated to -3.0 ml and protein (Pa), TC, and PL were determined as described in Materials and Methods. In separate experiments, using TC and PL as a measure of lipid recovery, we found that -70% was recovered from CSF after both chromatography and centrifugation.
hausen, 1986), have been shown to be efficient acceptors of cholesterol from cultured cells. It is possible that nascent A-LPs, such as those characterized herein, could participate in the efflux of free cholesterol from neural cells. Further studies will be required to address whether this occurs. Lecithin:cholesterol acyltransferase (LCAT) catalyzes the esterification of FC to CE in HDL, facilitating transport of cholesterol as a component of the HDL core. Evidence suggests that this enzyme is synthesized in the brain (Warden et a!., 1989; Smith eta!., 1990) and may function in a manner comparable with that in reverse cholesterol transport in the plasma (Fielding and Fielding, 1995) . There is also evidence for the synthesis of CE transfer protein (CETP) in the brain (Albers eta!., 1992) . This enzyme promotes the transfer of CE to HDL and is an alternative process by which the nascent A-LPs would have the potential to acquire CE. It is also possible that even in the absence of LCAT and CETP, apoE-containing A-LPs could play a role in sterol redistribution. For example, it has been shown that in the plasma of subjects with no plasma LCAT activity, apoE-containing HDL disks (Forte and Nordhausen, 1986 ) participate in cellular cholesterol efflux and influx (Fielding et a!., 1982) . Study of the processes involved in the generation of spherical CSF-LPs will contribute to a better understanding of lipoprotein metabolism in the CNS.
The function of the CNS lipoproteins may involve the redistribution of lipid, including both delivery and clearance. A-LP particles presumably travel through the interstitial space and are ultimately filtered into the CSF and cleared along with other CSF components. CNS lipoproteins are probably derived from both astrocytes and microglia. Because >95% of the cells in our cultures are astrocytes, microglial-derived lipoproteins are likely to have contributed only a very small fraction to the total secreted lipoproteins we assessed. Because microglia can, however, synthesize apoE (Nakai et a!., 1996; Stone et a!., 1997) and are activated under different conditions, future studies of microglial-derived lipoproteins will be of interest. Based on the localization of apolipoproteins and their receptors, it is likely that apoE-containing A-LPs play an important role in the uptake of lipid by glia and neurons, but the function of apoJ-containing particles is less clear. The function of A-LPs is probably dependent on whether apoE and apoJ are in the same or distinct particles. Our preliminary experiments, using coimmunoprecipitation of A-LPs under nondenaturing conditions, suggest that most if not all apoJ is found in apoE-containing particles (C. Reardon and M. J. LaDu, unpublished observations). Whether all apoE-containing A-LPs contain apoJ is under investigation. ApoJ may play a role in the CNS, as it is produced by neurons and astrocytes (Danik et a!., 1993) and up-regulated by astrocytes after injury (May and Finch, 1992) . However, gp330, the only known apoJ receptor, is expressed by ependyma! cells lining the ventricles and not by neurons and glia within the brain parenchyma (Kounnas et al., 1994) . Thus, if A-LPs contained only apoi, they would not mediate the uptake of A-LP by cells until they reach the CSF. Because our preliminary data suggest that most A-LPs containing apoJ also contain apoE, further studies to determine which receptors interact with these particles will be required. ApoE is also expressed by astrocytes in the brain and its expression is up-regulated after brain injury (Poirier et al., 1991) . In contrast to apoJ, several apoE receptors are expressed by neurons [LDL receptor, LDL receptor-related protein (LRP), VLDL receptor, and apoER2] (Moestrup et a!., 1992; Rebeck et al., 1993; Christie et a!., 1996; Kim et al., 1996) , astrocytes (LDL receptor) (Pitas et a!., 1987a) , and microglia (LRP) (Moestrup eta!., 1992) . Recent data indicate that polymorphisms in the LRP gene may be a risk factor for AD (Kang et a!., 1987; Lendon et a!., 1997) , and one study suggests a potential role for apoE-containing A-LPs in modulating neuronal process outgrowth through LRP (Narita et a!., 1997) . Thus, the expression of apoE and its receptors within the brain as well as their genetic links to AD suggest that further characterization of apoE-containing A-LPs will give insight into its normal and disease-related functions.
CSF-LPs appear to be heterogeneous in both composition and origin. It was first demonstrated by Roheim and coworkers in 1979 that human CSF contained lipoproteins, with apoE and apoAl being the two most abundant apolipoproteins (Roheim et al., 1979) . Using immunoaffinity and heparin-Sepharose columns, Pitas and co-workers (1987b) found that apoE and apoAl were predominantly in distinct lipoprotein particles that were HDL-!ike in buoyancy. In the CNS, apoAl does not appear to be an endogenous apolipoprotein, as its mRNA has not been localized in the brain (El -FIG. 4 . Protein distribution in human CSF and conditioned media from primary rat astrocytes fractionated by size. Selected fractions from gel-filtration chromatography of CSF (A, C, E, G, and H) and astrocyte-conditioned media (B, D, and F) were subjected to SDS-PAGE in reducing Laemmli buffer (5% /3ME, final concentration) and Coomassie stained (A and B) or run in nonreducing Laemmli buffer, transferred to Immobilon-P membrane, probed for immunoreactivity, and visualized by ECL (C-H). Primary antibodies used: C, human apoE; D, rat apoE; E, human apoJ; F, rat apoJ; G, human apoAl; H, human apoAll.
shourbagy et al., 1985) , nor did we detect apoAl in A-LPs in this study. Whereas apoAl and apoAll in CSF appear to be derived from the plasma, apoE is synthesized within the CNS (Boyles et a!., 1985; Poirier, 1994 ) and does not cross the blood-brain barrier (Linton et al., 1991) . ApoJ is also synthesized within the CNS, but the plasma contribution to apoi-contaming CSF-LPs is not clear. Thus, CSF lipoproteins contain a mixture of endogenous (derived from within the CNS) and exogenous (derived from plasma) apolipoproteins.
To examine physiologically relevant particles, lipo-
FIG. 5.
Negative-stained electron micrographs of lipoproteins from human CSF and rat astrocyte-conditioned media. Lipoproteins were isolated by gel-filtration chromatography and a concentrated aliquot (0.5 mg of protein/mi) from fractions 37/38 (A) and 43/44 (B) of CSF and 37/38 (C) of astrocyte media was placed on a carbon-coated electron microscopy grid and negatively stained with 2% phosphotungstic acid. Size bar is 25 nm. Arrows indicate a large spherical particle from human CSF (A), a small spherical particle from human CSF (B), and a stack of discoidal particles from rat astrocyte-conditioned media (C).
proteins from primary rat astrocytes and fresh human CSF were compared. We used techniques for culturing astrocytes from postnatal rodents, which are similar to those used by many laboratories (Goslin and Banker, 1991; Rose et a!., 1993) . Whether use of astrocyte cultures derived from adult tissue would result in cells with similar or different properties, with regard to secretion of A-LPs, than those reported here is unclear but can be addressed in future studies. Although information is limited, human and rat CSF appear comparable in terms of the presence of apoE and apoAl on HDL-sized particles (Chiba et a!., 1991) . Human astrocytoma cells secrete apoE-containing HDL-sized particles similar to those described here (Krul and Tang, 1992) . We think it is unlikely that species differences contribute to the general properties of the CNS lipoprotein particles that we characterized; however, it is noteworthy that species differences in apolipoproteins could result in structural differences between lipoprotein particles. Therefore, further studies are required to determine whether our results with rat-derived A-LPs are species dependent and generalizable to human-derived A-LPs. The major methodological finding in our study was that density centrifugation affected significantly the composition of CSF-LPs and A-LPs. Density centrifugation of CSF and, to a smaller degree, astrocyte-conditioned media resulted in dissociation of apolipoproteins from lipoprotein particles. In contrast, after gel Small CSF spheres 11.4 ±0.22
Lipoproteins from astrocyte media (discs) and CSF (spherical particles) were visualized by electron microscopy as described in the legend to Fig. 5 . Particles from a quadrant of enlarged prints of photomicrographs were measured by using a micrometer lens. Diameter of particles is expressed as the mean ± SEM of 100 particles.
filtration, apolipoproteins remained in lipoprotein-contaming fractions. In addition, by gel-filtration chromatography, we observed heterogeneity in the apolipoprotein distribution on the CSF-LPs. Although the total lipid composition of CSF lipoproteins, which we and others (Pitas et al., l987b ) determined after density centrifugation, was similar to that observed after gel filtration, a significant amount of protein (including apoE and apoJ) was lost from the lipoprotein fractions during ultracentrifugation. This has been described previously with apoE and plasma lipoproteins (Castro and Fielding, 1984) . This finding indicates that gelfiltration chromatography or other methods such as immunoaffinity chromatography, which preserve the protein composition of lipoproteins, should be used to preserve the endogenous structure and function of CNS-derived lipoprotein particles. This will be especially important in studies where the goal is to compare CNS-derived lipoproteins in a disease state or after experimental manipulations. Optimization of a gel-filtration column for particular particle sizes may allow for detection of subtle compositional differences.
Understanding the role of apoE-containing particles in the CNS, particularly any functions that may exhibit isoform-specific differences, may further our understanding of certain CNS pathologies. The 4 allele of apoE is a risk factor for AD (Strittmatter and Roses, 1996) as well as for poor recovery after certain brain injuries (Albers et al., 1992; Nicoll et al., 1995) . Although the mechanism for these associations is still unknown, two general observations may be relevant for these associations. First, apoE and apoE-containing lipoproteins have been shown to interact with /3-amybid (A/3) both in vitro (Strittmatter et al., 1993a,b; LaDu et al., 1994 LaDu et al., , 1995 and in vivo in the brains of AD patients (Namba et al., 1991; Naslund eta!., 1995) and after head trauma (Nicoll et al., 1995) . Furthermore, apoE can influence the rate of A/3 fibril formation in vitro (Evans et a!., 1994; Wood eta!., 1996) . It is possible that because of isoform-specific interactions between apoE and A/3, there is increased aggregation and deposition or decreased clearance of A/3 in the presence of apoE4 compared with other apoE isoforms. Given these potential interactions, it is noteworthy that soluble A/3 is found associated with lipoproteins in both plasma (Koudinov et a!., 1994; Biere et al., 1996) and CSF (Koudinov et al., 1996) . In addition, it is of interest that apoE3 but not apoE4 inhibits A/3-induced neurotoxicity in several in vitro models (Miyata and Smith, 1996; Jordan et al., 1998) , suggesting that apoE may have an isoform-specific effect on the toxicity of A~3 in vivo. Second, apoE-containing lipoproteins have been shown to influence neurona! structure in an isoform-specific manner such that apoE3-containing lipoproteins augment neurite outgrowth in vitro to a greater extent than apoE4-containing lipoproteins (Nathan et al., 1994; Holtzman et al., 1995) . These observations suggest the possibility that there is decreased structural plasticity in the brains of subjects who express apoE4.
In total, these findings show clear structural and compositional differences between lipoproteins found in CSF and those secreted by astrocytes. These differences may result in different biological functions of these particles and suggest the issue of which particles are the most relevant mode! of CNS lipoproteins. Our data suggest that new insights into the role of apoE and lipoproteins in the normal and injured brain can be obtained if CNS lipoproteins are isolated by techniques that preserve native particle composition. In addition, because lipoproteins secreted by astrocytes are exposed immediately to other cells in brain parenchyma after secretion, further studies of composition, function, and interactions of astrocyte-secreted lipoprotein particles will be important.
